Report
EUR 13.44 For Business Accounts Only

A double requalification allows RAIA DROGASIL ON to improve to Slightly Positive

RAIA DROGASIL ON (BR), a company active in the Drug Retailers industry, has received a double requalification by the independent financial analyst theScreener. Its fundamental valuation is now 2 out of 4 stars while its market behaviour can be considered as defensive. theScreener believes that the gain of a star(s) and an improvement in the market risk perception allows upgrading the general evaluation to Slightly Positive. As of the analysis date October 29, 2021, the closing price was BRL 23.25 and its potential was estimated at BRL 27.31.
Underlying
Raia Drogasil S.A.

Raia Drogasil is drugstore and pharmaceutical retail group based in Brazil. Co. is primarily engaged in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Co. operates predominately through two retail brands: Drogasil and Droga Raia. Product lines include Needs, Pluii and B-Well. Sales are carried out by 1,235 stores, located in 18 Brazilian states, including the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Goias, Parana, the Distrito Federal, Santa Catarina, Espirito Santo, Rio Grande do Sul, Bahia, Mato Grosso do Sul and Mato Grosso.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch